Center for Scientific Review; Notice of Closed Meetings, 67767-67769 [2023-21590]

Download as PDF 67767 Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices TABLE 1—RECIPIENTS AND SUPPLEMENT AWARD AMOUNTS Grant No. Award recipient name U1IMC45814 .................................................. U1IMC43532 .................................................. Children’s National Medical Center .................................................... University Hospitals Cleveland Medical Center ................................. Amount of Non-Competitive Award(s): Two awards at $400,000 per grant recipient totaling $800,000. Project Period: September 1, 2023, to August 31, 2024. Assistance Listing (CFDA) Number: 93.110. Award Instrument: Supplement for RPPN support services. Justification: Approximately $400,000 in supplemental funding has been awarded to each RPPN cooperative agreement recipient to increase activities to coordinate among the nation’s pediatric hospitals and their communities to prepare for and respond to global health threats and coordinate research-informed responses to future pandemics. Projects approved by HRSA under this supplement are to be performed from the date of award through August 31, 2024. Carole Johnson, Administrator. [FR Doc. 2023–21670 Filed 9–29–23; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Charter Renewal for the Advisory Committee on Infant and Maternal Mortality Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, the Department of Health and Human Services is giving notice that the Advisory Committee on Infant and Maternal Mortality (ACIMM or Committee) is renewed. The effective date of the charter renewal is September 30, 2023. FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Designated Federal Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, Room 18N84, Rockville, Maryland 20857; 301–443–0543; or VLee1@ hrsa.gov. SUPPLEMENTARY INFORMATION: ACIMM is authorized by section 222 of the Public lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:41 Sep 29, 2023 Jkt 262001 Health Service Act (42 U.S.C. 217a), as amended. The Committee is governed by provisions of Public Law 92–463, as amended (5 U.S.C. 10), which sets forth standards for the formation and use of Advisory Committees. ACIMM advises the Secretary of Health and Human Services on department activities, partnerships, policies, and programs directed at reducing infant mortality, maternal mortality and severe maternal morbidity, and improving the health status of infants and women before, during, and after pregnancy. The Committee provides advice on how best to coordinate Federal, State, local, Tribal, and Territorial governmental efforts designed to improve infant mortality, related adverse birth outcomes, and maternal health, as well as influence similar efforts in the private and voluntary sectors. The Committee provides guidance and recommendations on the policies, programs, and resources required to address the disparities and inequities in infant mortality, related adverse birth outcomes and maternal health outcomes, including maternal mortality and severe maternal morbidity. With its focus on underlying causes of the disparities and inequities seen in birth outcomes for women and infants, the Committee advises the Secretary of Health and Human Services on the health, social, economic, and environmental factors contributing to the inequities and proposes structural, policy and/or systems level changes. The charter renewal for ACIMM was approved on September 8, 2023. The filing date is September 30, 2023. Renewal of the ACIMM charter gives authorization for the committee to operate until September 30, 2025. A copy of the ACIMM charter is available on the ACIMM website at https://www.hrsa.gov/advisorycommittees/infant-mortality/. A copy of the charter also can be obtained by accessing the FACA database that is maintained by the Committee Management Secretariat under the General Services Administration. The website address for PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 City, state Award amount MD OH $400,000 400,000 the FACA database is https:// www.facadatabase.gov/. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2023–21716 Filed 9–29–23; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Cardiovascular and Respiratory Sciences Integrated Review Group, Therapeutic Development and Preclinical Studies Study Section. Date: October 25–26, 2023. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Contact Person: Richard D Schneiderman, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4138, Bethesda, MD 20817, 301–402–3995, richard.schneiderman@nih.gov. Name of Committee: Interdisciplinary Molecular Sciences and Training Integrated Review Group, Cellular and Molecular Technologies Study Section. Date: October 25–26, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Tatiana V Cohen, Ph.D., Scientific Review Officer, Center for E:\FR\FM\02OCN1.SGM 02OCN1 lotter on DSK11XQN23PROD with NOTICES1 67768 Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5213, Bethesda, MD 20892, 301–455–2364, tatiana.cohen@nih.gov. Name of Committee: Cardiovascular and Respiratory Sciences Integrated Review Group, Integrative Myocardial Physiology/ Pathophysiology A Study Section. Date: October 25–26, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Abdelouahab Aitouche, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4222, MSC 7814, Bethesda, MD 20892, 301–435– 2365, aitouchea@csr.nih.gov. Name of Committee: Infectious Diseases and Immunology A Integrated Review Group, Molecular and Cellular Biology of Virus Infection Study Section. Date: October 25–26, 2023. Time: 9:30 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Kenneth M Izumi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, MSC 7808, Bethesda, MD 20892, (301) 496–6980, izumikm@csr.nih.gov. Name of Committee: Center for Scientific Review, Special Emphasis Panel, Member Conflict: Topics in Biobehavioral Processes. Date: October 25, 2023. Time: 10:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Courtney M Pollack, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–3671, courtney.pollack@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Fellowships: Sensory and Motor Neurosciences, Cognition and Perception. Date: October 25–26, 2023. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: John N Stabley, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–0566, stableyjn@ csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Special Topics: Brain Imaging, Vision, Bioengineering and Low Vision Technology Development. VerDate Sep<11>2014 18:41 Sep 29, 2023 Jkt 262001 Date: October 26–27, 2023. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Capitol, 550 C Street, SW Washington, DC 20024. Contact Person: Susan Gillmor, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 762–3076, susan.gillmor@ nih.gov. Name of Committee: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group, Emerging Imaging Technologies and Applications Study Section. Date: October 26–27, 2023. Time: 8:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: North Bethesda Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Zheng Li, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301–594–3385, zheng.li3@nih.gov. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group, Chemical Synthesis and Biosynthesis Study Section. Date: October 26–27, 2023. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Shan Wang, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496–4390, shan.wang@nih.gov. Name of Committee: Infectious Diseases and Immunology A Integrated Review Group, Cellular and Molecular Immunology—A Study Section. Date: October 26–27, 2023. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Blvd., Gaithersburg, MD 20878. Contact Person: Mohammad Samiul Alam, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 809D, Bethesda, MD 20892, (301) 435–1199, alammos@csr.nih.gov. Name of Committee: Infectious Diseases and Immunology A Integrated Review Group Cellular and Molecular Immunology—B Study Section Date: October 26–27, 2023 Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications Place: The William F. Bolger Center 9600 Newbridge Drive Potomac, MD 20854 Contact Person: Liying Guo, Ph.D. Scientific Review Officer Center for Scientific Review National Institutes of Health 6701 Rockledge Drive, Room 4198, MSC 7812 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Bethesda, MD 20892 (301) 827–7728 lguo@ mail.nih.gov. Name of Committee: Infectious Diseases and Immunology B Integrated Review Group Hypersensitivity, Autoimmune, and Immunemediated Diseases Study Section. Date: October 26–27, 2023. Time: 8:30 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza National Airport, 1480 Crystal Drive, Arlington, VA 22202. Contact Person: Xinrui Li, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–2084, xinrui.li@nih.gov. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group, Pathophysiology of Obesity and Metabolic Disease Study Section. Date: October 26–27, 2023. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites Alexandria, Old Town, 1900 Diagonal Road, Alexandria, VA 22314. Contact Person: Heather Marie Brockway, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 813H, Bethesda, MD 20892, (301) 594–5228, brockwayhm@csr.nih.gov. Name of Committee: Digestive, Kidney and Urological Systems Integrated Review Group Hepatobiliary Pathophysiology Study Section. Date: October 26–27, 2023. Time: 9:00 a.m. to 8:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Jianxin Hu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2156, Bethesda, MD 20892, 301–827–4417, jianxinh@csr.nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group, Neuronal Communications Study Section. Date: October 26–27, 2023. Time: 9:00 a.m. to 8:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Prithi Rajan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435–1042, prithi.rajan@nih.gov. Name of Committee: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group, Imaging Technology Development Study Section. Date: October 26–27, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\02OCN1.SGM 02OCN1 lotter on DSK11XQN23PROD with NOTICES1 Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices Place: National Institutes of Health Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892, (Virtual Meeting). Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, (301) 237– 9870, xuguofen@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group, Maximizing Investigators’ Research Award—D Study Section. Date: October 26–27, 2023. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Linda MacArthur, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4187, Bethesda, MD 20892, 301–537–9986, macarthurlh@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group, Acute Neural Injury and Epilepsy Study Section. Date: October 26–27, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20892, 301–760–8207, schauweckerpe@csr.nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group, Organization and Delivery of Health Services Study Section. Date: October 26–27, 2023. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Catherine Hadeler Maulsby, Ph.D., MPH Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435–1266, maulsbych@csr.nih.gov. Name of Committee: Biobehavioral and Behavioral Processes Integrated Review Group, Motor Function, Speech and Rehabilitation Study Section. Date: October 26–27, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Stephanie Nagle Emmens, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–6604, nagleemmenssc@ csr.nih.gov. VerDate Sep<11>2014 18:41 Sep 29, 2023 Jkt 262001 (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 26, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–21590 Filed 9–29–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Medical Imaging Investigations. Date: November 6, 2023. Time: 9 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Khalid Masood, Ph.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5120, MSC 7854, Bethesda, MD 20892, 301–435– 2392, masoodk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Biobehavioral Processes. Date: November 6–7, 2023. Time: 10 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jeanne M. McCaffery, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, 301–594–3854, jeanne.mccaffery@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 67769 Conflict: Topics in Vaccines Against Infectious Diseases and Vector-Borne and Zoonotic Diseases. Date: November 6, 2023. Time: 10 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shinako Takada, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301–827–5997, shinako.takada@ nih.gov. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Cardiovascular and Respiratory Diseases Study Section. Date: November 7–8, 2023. Time: 8 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Hybrid Meeting). Contact Person: Mohammed F.A. Elfaramawi, Ph.D., MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1007F, Bethesda, MD 20892, (301) 480–1142, elfaramawimf@csr.nih.gov. Name of Committee: Applied Immunology and Disease Control Integrated Review Group; Drug Discovery and Molecular Pharmacology A Study Section. Date: November 7–8, 2023. Time: 8:30 a.m. to 7:30 p.m. Agenda: To review and evaluate grant applications. Place: DoubleTree by Hilton McLean Tysons, 1960 Chain Bridge Road, Mclean, VA 22102. Contact Person: Bidyottam Mittra, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892, (301) 435–0000, bidyottam.mittra@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Oncology. Date: November 7–8, 2023. Time: 10 a.m. to 8 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nywana Sizemore, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6189, MSC 7804, Bethesda, MD 20892, 301–408– 9916, sizemoren@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Aging, Infection, and Cellular Signaling. Date: November 7, 2023. Time: 11 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). E:\FR\FM\02OCN1.SGM 02OCN1

Agencies

[Federal Register Volume 88, Number 189 (Monday, October 2, 2023)]
[Notices]
[Pages 67767-67769]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21590]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Cardiovascular and Respiratory Sciences 
Integrated Review Group, Therapeutic Development and Preclinical 
Studies Study Section.
    Date: October 25-26, 2023.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW, Washington, DC 20015.
    Contact Person: Richard D Schneiderman, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4138, Bethesda, MD 20817, 301-
402-3995, [email protected].

    Name of Committee: Interdisciplinary Molecular Sciences and 
Training Integrated Review Group, Cellular and Molecular 
Technologies Study Section.
    Date: October 25-26, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Tatiana V Cohen, Ph.D., Scientific Review 
Officer, Center for

[[Page 67768]]

Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 5213, Bethesda, MD 20892, 301-455-2364, 
[email protected].

    Name of Committee: Cardiovascular and Respiratory Sciences 
Integrated Review Group, Integrative Myocardial Physiology/
Pathophysiology A Study Section.
    Date: October 25-26, 2023.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Abdelouahab Aitouche, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4222, MSC 7814, Bethesda, MD 
20892, 301-435-2365, [email protected].

    Name of Committee: Infectious Diseases and Immunology A 
Integrated Review Group, Molecular and Cellular Biology of Virus 
Infection Study Section.
    Date: October 25-26, 2023.
    Time: 9:30 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Kenneth M Izumi, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, MSC 7808, Bethesda, MD 20892, (301) 
496-6980, [email protected].

    Name of Committee: Center for Scientific Review, Special 
Emphasis Panel, Member Conflict: Topics in Biobehavioral Processes.
    Date: October 25, 2023.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Courtney M Pollack, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-3671, 
[email protected].
    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Fellowships: Sensory and Motor Neurosciences, Cognition and 
Perception.
    Date: October 25-26, 2023.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: John N Stabley, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0566, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Special Topics: Brain Imaging, Vision, Bioengineering and Low 
Vision Technology Development.
    Date: October 26-27, 2023.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Capitol, 550 C Street, SW Washington, DC 
20024.
    Contact Person: Susan Gillmor, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (240) 762-3076, 
[email protected].

    Name of Committee: Surgical Sciences, Biomedical Imaging and 
Bioengineering Integrated Review Group, Emerging Imaging 
Technologies and Applications Study Section.
    Date: October 26-27, 2023.
    Time: 8:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: North Bethesda Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Zheng Li, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, 301-594-3385, 
[email protected].
    Name of Committee: Biological Chemistry and Macromolecular 
Biophysics Integrated Review Group, Chemical Synthesis and 
Biosynthesis Study Section.
    Date: October 26-27, 2023.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Shan Wang, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 496-4390, 
[email protected].

    Name of Committee: Infectious Diseases and Immunology A 
Integrated Review Group, Cellular and Molecular Immunology--A Study 
Section.
    Date: October 26-27, 2023.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Blvd., Gaithersburg, MD 20878.
    Contact Person: Mohammad Samiul Alam, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 809D, Bethesda, MD 20892, (301) 
435-1199, [email protected].

    Name of Committee: Infectious Diseases and Immunology A 
Integrated Review Group Cellular and Molecular Immunology--B Study 
Section
    Date: October 26-27, 2023
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications
    Place: The William F. Bolger Center 9600 Newbridge Drive 
Potomac, MD 20854
    Contact Person: Liying Guo, Ph.D. Scientific Review Officer 
Center for Scientific Review National Institutes of Health 6701 
Rockledge Drive, Room 4198, MSC 7812 Bethesda, MD 20892 (301) 827-
7728 [email protected].

    Name of Committee: Infectious Diseases and Immunology B 
Integrated Review Group Hypersensitivity, Autoimmune, and Immune-
mediated Diseases Study Section.
    Date: October 26-27, 2023.
    Time: 8:30 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crowne Plaza National Airport, 1480 Crystal Drive, 
Arlington, VA 22202.
    Contact Person: Xinrui Li, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 594-2084, 
[email protected].

    Name of Committee: Endocrinology, Metabolism, Nutrition and 
Reproductive Sciences Integrated Review Group, Pathophysiology of 
Obesity and Metabolic Disease Study Section.
    Date: October 26-27, 2023.
    Time: 8:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites Alexandria, Old Town, 1900 Diagonal Road, 
Alexandria, VA 22314.
    Contact Person: Heather Marie Brockway, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 813H, Bethesda, MD 20892, (301) 
594-5228, [email protected].

    Name of Committee: Digestive, Kidney and Urological Systems 
Integrated Review Group Hepatobiliary Pathophysiology Study Section.
    Date: October 26-27, 2023.
    Time: 9:00 a.m. to 8:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Jianxin Hu, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 2156, Bethesda, MD 20892, 301-827-4417, 
[email protected].
    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group, Neuronal Communications Study 
Section.
    Date: October 26-27, 2023.
    Time: 9:00 a.m. to 8:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Prithi Rajan, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 435-1042, 
[email protected].
    Name of Committee: Surgical Sciences, Biomedical Imaging and 
Bioengineering Integrated Review Group, Imaging Technology 
Development Study Section.
    Date: October 26-27, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 67769]]

    Place: National Institutes of Health Rockledge II, 6701 
Rockledge Drive Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, (301) 237-
9870, [email protected].

    Name of Committee: Cell Biology Integrated Review Group, 
Maximizing Investigators' Research Award--D Study Section.
    Date: October 26-27, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Linda MacArthur, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4187, Bethesda, MD 20892, 301-
537-9986, [email protected].
    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group, Acute Neural Injury and Epilepsy Study 
Section.
    Date: October 26-27, 2023.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20892, 301-
760-8207, [email protected].

    Name of Committee: Healthcare Delivery and Methodologies 
Integrated Review Group, Organization and Delivery of Health 
Services Study Section.
    Date: October 26-27, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Catherine Hadeler Maulsby, Ph.D., MPH Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1266, 
[email protected].
    Name of Committee: Biobehavioral and Behavioral Processes 
Integrated Review Group, Motor Function, Speech and Rehabilitation 
Study Section.
    Date: October 26-27, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Stephanie Nagle Emmens, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-6604, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)


    Dated: September 26, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-21590 Filed 9-29-23; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.